RENAL ALLOGRAFT OUTCOMES IN LIVE DONOR RECIPIENTS ON TACROLIMUS BASED TRIPLE IMMUNOSUPPRESSION WITH AND WITHOUT BASILIXIMAB INDUCTION

被引：0
|
作者：
Sakhuja, Vinay [1 ]
Gundlapalli, Srikanth [1 ]
Rathi, Manish [1 ]
Jha, Vivekanand [1 ]
Kohli, H. S. [1 ]
Sharma, Ashish [1 ]
Minz, M. [1 ]
机构：
[1] PGIMER, Chandigarh, India
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：513 / 513
页数：1
相关论文
共 50 条
  • [31] REJECTION EPISODES, VIRAEMIA PREVALENCE AND IMMUNOSUPPRESSION SWITCHES WITHIN THE FIRST YEAR FOR PAEDIATRIC RENAL TRANSPLANT RECIPIENTS COMMENCED ON IMMUNOSUPPRESSION PROTOCOL OF AZATHIOPRINE, TACROLIMUS AND STEROIDS WITH BASILIXIMAB INDUCTION.
    Arslan, Zainab
    Ware, Nick
    Walsh, Granule
    Jones, Helen
    PEDIATRIC NEPHROLOGY, 2018, 33 (10) : 1963 - 1964
  • [32] LIVE DONOR RENAL-TRANSPLANTATION WITH LOW-DOSE TRIPLE IMMUNOSUPPRESSION
    FRANCIS, DMA
    MILLAR, RJ
    WALKER, RG
    NICHOLLS, K
    POWELL, H
    JONES, C
    KOCKELBERGH, R
    BECKER, G
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (05) : 2243 - 2243
  • [33] BASILIXIMAB VERSUS DACLIZUMAB COMBINED WITH TRIPLE IMMUNOSUPPRESSION IN DECEASED DONOR RENAL TRANSPLANTATION: A PROSPECTIVE RANDOMIZED STUDY
    Arnol, Miha
    Omahen, Katarina
    Oblak, Manca
    Bren, Andrej F.
    Kandus, Aljosa
    TRANSPLANT INTERNATIONAL, 2009, 22 : 80 - 81
  • [34] Randomised study of steroid free immunosuppression with basiliximab induction vs standard triple drug immunosuppression in adult live donor liver transplantation (LDLT). CTRI/2017/08/009508
    Kathirvel, M.
    Mathew, J. S.
    Binoj, S.
    Mallick, S.
    Varghese, C. T.
    Chandran, B.
    Unnikrishnan, G.
    Menon, R. N.
    Balakrishnan, D.
    Sudheer, O.
    Dhar, P.
    Sudhindran, S.
    TRANSPLANTATION, 2018, 102 : 32 - 32
  • [35] Economic implications of the use of basiliximab in addition to triple immunosuppressive therapy in renal allograft recipients - A UK perspective
    Walters, SJ
    Whitfield, M
    Akehurst, RL
    Chilcott, JB
    PHARMACOECONOMICS, 2003, 21 (02) : 129 - 138
  • [36] Basiliximab Versus Daclizumab Combined With Triple Immunosuppression in Deceased Donor Renal Transplantation: A Prospective, Randomized Study
    Kandus, Aljosa
    Arnol, Miha
    Omahen, Katarina
    Oblak, Manca
    Vidan-Jeras, Blanka
    Kmetec, Andrej
    Bren, Andrej F.
    TRANSPLANTATION, 2010, 89 (08) : 1022 - 1027
  • [37] Prevention of early acute rejection with daclizumab and triple immunosuppression in cadaveric renal allograft recipients
    Kandus, AA
    Grego, K
    Bren, AF
    THERAPEUTIC APHERESIS AND DIALYSIS, 2005, 9 (03) : 262 - 264
  • [38] Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression
    Soran, A
    Basar, H
    Shapiro, R
    Vivas, C
    Scantlebury, VP
    Jordan, ML
    Gritsch, HA
    McCauley, J
    Randhawa, P
    Hakala, TR
    Fung, JJ
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (03) : 663 - 664
  • [39] Comparison of Clinical Outcomes of Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients.
    Wen, X.
    Casey, M.
    Santos, A.
    Hartzema, A.
    Womer, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 305 - 305
  • [40] Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients
    Wen, X.
    Casey, M. J.
    Santos, A. H.
    Hartzema, A.
    Womer, K. L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (11) : 3202 - 3211
12345